← Leaderboards
Simon Petersen-Jones
Michigan State University
$4,255,460
Attributed
$12,503,389
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–22$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$12,503,389 · 4
By mechanism
R24$8,578,416 · 1
R44$2,230,814 · 1
R01$1,694,159 · 2
Top collaborators
- William W Hauswirth6 shared
- Stylianos Michalakis6 shared
- Stephen H Tsang6 shared
- Igor O. Nasonkin3 shared
- Magdalene J Seiler3 shared
- Vladimir Jivkov Kefalov1 shared
- Philip David Kiser1 shared
- Krzysztof Palczewski1 shared
Most similar at Michigan State University
Same institution · by research overlap
- Stylianos Michalakis$2,144,604
Others in their field
Top investigators on “Retinitis Pigmentosa”
- Keri Hammel · The Emmes Company, Llc$46,456,947
- Krzysztof Palczewski · University Of California-Irvine$33,155,003
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Martin Friedlander · Scripps Research Institute$20,871,116
- Robert Jay Greenberg · Second Sight Medical Products, Inc.$17,690,386
- Gustavo David Aguirre · University Of Pennsylvania$17,591,050
Research focus
Retinitis PigmentosaProductionMutationGene TherapyAnimal ModelAnimalsBlindnessRattusElectroretinographyClinical TrialsRetinal DegenerationStructureFuturePhotoreceptorsPhotoreceptor DegenerationRetinaRetinal RodsGenesPreservationReporter GenesOptical Coherence TomographyLinkGene ExpressionEfficacy Study
Grant awards (14)
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,517,749
R24 · FY2022 · EY · contact PI
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,828,029
R24 · FY2021 · EY · contact PI
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$363,550
R24 · FY2021 · EY · contact PI
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,832,126
R24 · FY2020 · EY · contact PI
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,783,428
R24 · FY2019 · EY · contact PI
Retinal tissue derived from human pluripotent stem cells for vision restoration$670,621
R44 · FY2019 · EY
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa$1,253,534
R24 · FY2018 · EY · contact PI
Retinal tissue derived from human pluripotent stem cells for vision restoration$743,345
R44 · FY2018 · EY
Retinal tissue derived from human pluripotent stem cells for vision restoration$816,848
R44 · FY2017 · EY
Retinoids in Vision$435,877
R01 · FY2016 · EY
Gene Therapy of Autosomal Recessive RP$310,635
R01 · FY2006 · EY · contact PI
Gene Therapy of Autosomal Recessive RP$318,110
R01 · FY2005 · EY
Gene Therapy of Autosomal Recessive RP$313,655
R01 · FY2004 · EY
Gene Therapy of Autosomal Recessive RP$315,882
R01 · FY2003 · EY